Postsurgical seizure outcome in temporal lobe epilepsy patients with normal or subtle, nonspecific MRI findings.

MRI-negative epilepsy outcome surgery

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
31 Dec 2021
Historique:
received: 05 01 2021
accepted: 14 10 2021
pubmed: 1 1 2022
medline: 1 1 2022
entrez: 31 12 2021
Statut: aheadofprint

Résumé

The authors' objective was to report postsurgical seizure outcome of temporal lobe epilepsy (TLE) patients with normal or subtle, nonspecific MRI findings and to identify prognostic factors related to seizure control after surgery. This was a retrospective study of patients who underwent surgery from 1999 to 2014 at two comprehensive epilepsy centers. Patients with a clear MRI lesion according to team discussion and consensus were excluded. Presurgical information, surgery details, pathological data, and postsurgical outcomes were retrospectively collected from medical charts. Multiple logistic regression analysis was used to assess the effect of clinical, surgical, and neuroimaging factors on the probability of Engel class I (favorable) versus class II-IV (unfavorable) outcome at last follow-up. The authors included 73 patients (59% were female; median age at surgery 35.9 years) who underwent operations after a median duration of epilepsy of 13 years. The median follow-up after surgery was 30.6 months. At latest follow-up, 44% of patients had Engel class I outcome. Favorable prognostic factors were focal nonmotor aware seizures and unilateral or no spikes on interictal scalp EEG. Favorable outcome can be achieved in a good proportion of TLE patients with normal or subtle, nonspecific MRI findings, particularly when presurgical investigation suggests a rather circumscribed generator. Presurgical factors such as the presence of focal nonmotor aware seizures and unilateral or no spikes on interictal EEG may indicate a higher probability of seizure freedom.

Identifiants

pubmed: 34972090
doi: 10.3171/2021.10.JNS2127
pii: 2021.10.JNS2127
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Auteurs

Karina A González Otárula (KA)

1Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Yee-Leng Tan (YL)

1Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.
3Department of Neurology, National Neuroscience Institute, Singapore.

Jeffery A Hall (JA)

1Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Edward F Chang (EF)

2Department of Neurology, University of California, San Francisco Medical Center, San Francisco, California.

José A Correa (JA)

4Department of Mathematics and Statistics, McGill University, Montreal, Quebec, Canada.

François Dubeau (F)

1Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Viviane Sziklas (V)

1Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Jean-Paul Soucy (JP)

6PET Unit, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Marie-Christine Guiot (MC)

5Department of Pathology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada; and.

Robert C Knowlton (RC)

2Department of Neurology, University of California, San Francisco Medical Center, San Francisco, California.

Eliane Kobayashi (E)

1Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.

Classifications MeSH